Key result
Review summarizes current literature on simultaneous surgical ablation for AF during cardiac surgery.
Why the study?
Despite available pharmacologic and electrophysiological therapies, death and functional limitations related to atrial fibrillation remain common, prompting a review of simultaneous surgical ablation during cardiac surgery.
This review summarizes the current status of simultaneous surgical ablation for atrial fibrillation during cardiac surgery.
Summarizes current status of concomitant surgical AF ablation; leaves open optimal strategies and hard-endpoint data.
Atrial fibrillation (AF) is the most common cardiac arrhythmia with the rate of 1-2% in general population. It is characterized by the absence of coordinated pulses in the atrium and micro-re-entry. Increasing age, coronary artery disease and valve pathologies are the risk factors for the development of AF. It can be seen both non-cardiac surgery (10-20%) and cardiac surgery (20-40%). This disease is expected to double in the next 25 years. Despite current drug and electrophysiological treatments, death and functional limitations related to AF are still common. In this paper we present the current status of simultaneous surgical ablation for AF in the light of current literature.
No takes yet. Share an insight, caveat, or question.
Demirsoy et al. (2019) conducted a review in Atrial fibrillation. Simultaneous surgical ablation was evaluated. Simultaneous surgical ablation for atrial fibrillation during cardiac surgery is reviewed to present its current status in the light of current literature.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: